Spotlight Asset Group’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $111K | Hold |
700
| – | – | 0.08% | 100 |
|
|
2024
Q1 | $90.6K | Hold |
700
| – | – | 0.06% | 114 |
|
|
2023
Q4 | $84.9K | Hold |
700
| – | – | 0.08% | 107 |
|
|
2023
Q3 | $84.9K | Hold |
700
| – | – | 0.08% | 107 |
|
|
2023
Q2 | $80.2K | Buy |
+700
| New | +$80.2K | 0.07% | 108 |
|
|
2021
Q3 | $65K | Hold |
700
| – | – | 0.03% | 113 |
|
|
2021
Q2 | $54K | Hold |
700
| – | – | 0.02% | 127 |
|
|
2021
Q1 | $52K | Hold |
700
| – | – | 0.02% | 129 |
|
|
2020
Q4 | $119K | Hold |
700
| – | – | 0.04% | 131 |
|
|
2020
Q3 | $98K | Buy |
+700
| New | +$98K | 0.04% | 139 |
|
|
2020
Q2 | – | Sell |
-5,700
| Closed | -$558K | – | 148 |
|
|
2020
Q1 | $558K | Hold |
5,700
| – | – | 0.3% | 51 |
|
|
2019
Q4 | $620K | Buy |
+5,700
| New | +$620K | 0.3% | 54 |
|